Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01546285 · ClinicalTrials.gov registry record · NA
B40 Non-Invasive Blood Pressure Equivalency Study
A NA study, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT01546285: Completed NA study, sponsored by GE Healthcare.
NCT01546285 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01546285, a NA study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate equivalency of the GE Healthcare B40 Patient Monitor noninvasive blood pressure (NIBP) parameter compared to the reference device.
Primary Outcome
The primary endpoints are the difference in systolic, diastolic and mean blood pressure values between the B40 Monitor and PRO1000. The mean of the difference should be no more than 5mmHg and the standard deviation of the difference should be no more than 8mmHg per the AAMI SP-10 standard.
Interventions
- DEVICE Blood Pressure Readings on B40 Patient Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT01546285 record still lists
NCT01546285 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Blood Pressure Readings on B40 Patient Monitor is the first listed.
NCT01546285 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01546285 about?
NCT01546285 is a clinical study titled "B40 Non-Invasive Blood Pressure Equivalency Study". The purpose of this study is to demonstrate equivalency of the GE Healthcare B40 Patient Monitor noninvasive blood pressure (NIBP) parameter compared to the reference device.
What is the current status of trial NCT01546285?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2012-03. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01546285?
The interventions under investigation include: Blood Pressure Readings on B40 Patient Monitor (DEVICE).
Who is sponsoring clinical trial NCT01546285?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01546285's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia